insitro vs MeddiPop: Which is better?

Making Medicines. Differently. At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines. Robust Machine Learning Platform, Fueled by Data insitro’s ML-driven platform integrates in vitro cellular data produced in our labs with human clinical data to help redefine disease. Engineered to accelerate the development of new medicines, our platform precisely identifies therapeutic insights and interventions across a wide spectrum of diseases.

MeddiPop is an AI tool designed to match qualified patients with medical practices. The tool offers an intuitive dashboard to help medical practices keep track of patient leads. With the use of MeddiPop, medical practices can avoid heavy lifting in the process of attracting new patients and growing their practice. The AI routes patient leads to the most relevant medical practices based on their location, insurance, income, and other demographics. MeddiPop is currently in beta mode and available for a limited pricing period. The tool is suitable for healthcare professionals who are looking to grow their patient base and focus more on patient care, while leaving lead generation and patient-matching to AI.